49 related articles for article (PubMed ID: 16643617)
1. Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie's disease: a safety profile.
Yan S; Yap T; Minhas S
Transl Androl Urol; 2017 Feb; 6(1):123-126. PubMed ID: 28217460
[No Abstract] [Full Text] [Related]
2. Peyronie's disease: What's around the bend?
Bilgutay AN; Pastuszak AW
Indian J Urol; 2016; 32(1):6-14. PubMed ID: 26941488
[TBL] [Abstract][Full Text] [Related]
3. PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.
Bilgutay AN; Pastuszak AW
Curr Sex Health Rep; 2015 Jun; 7(2):117-131. PubMed ID: 26279643
[TBL] [Abstract][Full Text] [Related]
4. Update on medical management of Peyronie's disease.
Tan RB; Sangkum P; Mitchell GC; Hellstrom WJ
Curr Urol Rep; 2014 Jun; 15(6):415. PubMed ID: 24740275
[TBL] [Abstract][Full Text] [Related]
5. The non-surgical treatment of peyronie disease: 2013 update.
Shaw EJ; Mitchell GC; Tan RB; Sangkum P; Hellstrom WJ
World J Mens Health; 2013 Dec; 31(3):183-92. PubMed ID: 24459651
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological therapy in patients diagnosed with Peyronie's disease.
Halal AA; Geavlete P; Ceban E
J Med Life; 2012 Jun; 5(2):192-5. PubMed ID: 22802890
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
Paulis G; D'Ascenzo R; Nupieri P; De Giorgio G; Orsolini G; Brancato T; Alvaro R
Int J Androl; 2012 Aug; 35(4):521-7. PubMed ID: 21950543
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Management of Peyronie's Disease.
Trost LW; Gur S; Hellstrom WJ
Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
[TBL] [Abstract][Full Text] [Related]
9. Peyronie's disease: current management.
Fitkin J; Ho GT
Am Fam Physician; 1999 Aug; 60(2):549-52, 554. PubMed ID: 10465229
[TBL] [Abstract][Full Text] [Related]
10. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease.
Russell S; Steers W; McVary KT
Eur Urol; 2007 Mar; 51(3):640-7. PubMed ID: 17092631
[TBL] [Abstract][Full Text] [Related]
11. Outcome analysis for conservative management of Peyronie's disease.
Hashimoto K; Hisasue S; Kato R; Kobayashi K; Shimizu T; Tsukamoto T
Int J Urol; 2006 Mar; 13(3):244-7. PubMed ID: 16643617
[TBL] [Abstract][Full Text] [Related]
12. [Conservative treatment of Peyronie's disease: colchicine vs. colchicine plus vitamin E].
Cortés-González JR; Glina S
Actas Urol Esp; 2010 May; 34(5):444-9. PubMed ID: 20470717
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of Peyronie's disease.
Fenster HN; McLoughlin MG
Can J Surg; 1980 Sep; 23(5):471-3. PubMed ID: 7002272
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
